Vanta Bioscience Ltd
Vanta Bioscience Ltd Share Price Today: Live Updates & Key Insights
Get insights on Vanta Bioscience Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Vanta Bioscience Ltd Share Price Chart
VANTABIOSCIENCE at 10 Jul 2026 06:18 PM Healthcare Services
25.29 +1.20(+4.98%)
Lowest Today 25.29
Highest Today 25.29
Today's Open 25.29
Prev. Close 24.09
52 Week High 31.33
52 Week Low 14.71
Vanta Bioscience Ltd Fundamentals
Traded Volume: 750
Market Cap(Cr): 17.99
Avg Traded Price 25.29
1 Year return -4.24%
Upper Circuit 25.3
Lower Circuit 25.3
P/E TTM 0.00
P/B Ratio 0.00
Traded Value(Cr) 0.19
EPS TTM NaN
Book value/Share NaN
Dividend Yield 1Y 0.00%
Vanta Bioscience Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Vanta Bioscience Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Vanta Bioscience Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -4.24%
YTD 0.00%
Vanta Bioscience Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Vanta Bioscience Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Vanta Bioscience Ltd Technical Details
Vanta Bioscience Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 25
Support 2 25
Support 3 25
Pivot Point : 25
Resistance 1 25
Resistance 2 25
Resistance 3 25
Vanta Bioscience Ltd Corporate Actions
Vanta Bioscience Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Vanta Bioscience Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by VANTABIOSCIENCE
Bonus
No Bonus has been declared by VANTABIOSCIENCE
Splits
No Split has been declared by VANTABIOSCIENCE
Others
Rights No Rights has been declared by VANTABIOSCIENCE
Vanta Bioscience Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Vanta Bioscience Ltd with leading peers in the diversified consumer services sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Vanta Bioscience Ltd's relative performance and valuation against major competitors.
Stock Name Samsrita Labs Ltd ₹13.45 (+4.91%) M. Cap (Cr) 0.31 1 Yr Return (%) -30.74% P/E (TTM) -3.42 PB Ratio 2.62
Stock Name Deccan Health Care Ltd ₹13.39 (+0.68%) M. Cap (Cr) 0.33 1 Yr Return (%) -36.18% P/E (TTM) 12.19 PB Ratio 0.28
Stock Name Transgene Biotek Ltd ₹3.08 (0.00%) M. Cap (Cr) 0.23 1 Yr Return (%) -37.65% P/E (TTM) -14.12 PB Ratio 2.79
Stock Name Vanta Bioscience Ltd ₹25.29 (+4.98%) M. Cap (Cr) 0.18 1 Yr Return (%) -4.24% P/E (TTM) 166.08 PB Ratio 0.85
Stock Name Family Care Hospitals Ltd ₹2.96 (0.00%) M. Cap (Cr) 0.16 1 Yr Return (%) -32.42% P/E (TTM) -1.84 PB Ratio 1.69
Stock Name Dolphin Medical Services Ltd ₹8.67 (-4.93%) M. Cap (Cr) 0.13 1 Yr Return (%) +295.89% P/E (TTM) 213.92 PB Ratio 1.30
Stock Name Clinitech Laboratory Ltd ₹40.00 (0.00%) M. Cap (Cr) 0.09 1 Yr Return (%) NaN% P/E (TTM) 22.01 PB Ratio 0.99
Vanta Bioscience Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Vanta Bioscience Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -5.22 Mar 2025 1.36 Mar 2024 4.54 Mar 2023 0.64 Mar 2022 6.70
PARTICULARS Investing Activities Mar 2026 -6.87 Mar 2025 -5.79 Mar 2024 -1.67 Mar 2023 -2.53 Mar 2022 -8.05
PARTICULARS Financing Activities Mar 2026 12.08 Mar 2025 4.43 Mar 2024 -2.80 Mar 2023 1.88 Mar 2022 1.38
PARTICULARS Net Cash Flow Mar 2026 -0.01 Mar 2025 0.00 Mar 2024 0.07 Mar 2023 0.00 Mar 2022 0.00
Vanta Bioscience Ltd Shareholding Pattern
This shows the ownership breakdown of Vanta Bioscience Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Vanta Bioscience Ltd
Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017.VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. It also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers.The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as Vanta Bioscience (a toxicology division and commenced commercial activities in April, 2017. VBS has state of the art facilities and infrastructure necessary for conduct of all kind of toxicology studies for Chemicals, Pharmaceuticals, Cosmetics, Agrochemicals like Pesticides, Insecticides, Excipients, Novel Feed Additives. In addition, the Company conducts preclinical proof-of-concept (PoC) studies for novel pharmaceuticals and products intended for new indications in variety of animal models of human diseases through a robust process of validation. In September 2017, the Company came up with a Public Issue of 15,12,000 Equity Shares by raising money from public aggregating to Rs 7.56 Crore.In 2018-19, Vanta Clinical Research Limited and Vayam Research Solutions Limited became the subsidiaries of the Company.
Managing Director
Dopesh Raja Mulakala
Registered office No.02/G/308/G Umajay Complex, Rasoolpura Secunderabad, Hyderabad, Telangana, 500003
FAX :91-40-66575454
Background
Incorporation Year 2016
Face Value ₹10.00
Market Lot 1500
FAQs on Vanta Bioscience Ltd
How to buy Vanta Bioscience Ltd shares?
To buy Vanta Bioscience Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Vanta Bioscience Ltd?
The company has a market capitalization of ₹17.99.
What is the PE & PB ratio of Vanta Bioscience Ltd?
PE is N/A and PB is N/A.
What is the Vanta Bioscience Ltd dividend for 2025–26?
For the 2025–26 financial year, Vanta Bioscience Ltd declared a final dividend of null% per share.